Skip to main content
Augmedix, Inc. (AUGX)
NASDAQ: AUGX · IEX Real-Time Price · USD
2.530
-0.180 (-6.64%)
At close: May 1, 2024, 4:00 PM
2.620
+0.090 (3.56%)
After-hours: May 1, 2024, 5:24 PM EDT

Augmedix Revenue

In the year 2023, Augmedix had annual revenue of $44.86M with 45.01% growth. Revenue in the quarter ending December 31, 2023 was $12.68M with 44.90% year-over-year growth.

Revenue (ttm)
$44.86M
Revenue Growth
+45.01%
P/S Ratio
2.76
Revenue / Employee
$31,367
Employees
1,430
Market Cap
123.89M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202344.86M13.92M45.01%
Dec 31, 202230.93M8.77M39.56%
Dec 31, 202122.17M5.68M34.47%
Dec 31, 202016.48M2.38M16.84%
Dec 31, 201914.11M3.29M30.44%
Dec 31, 201810.82M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
P3 Health Partners 1.27B
Seres Therapeutics 126.33M
Electromed 51.69M
Repare Therapeutics 51.13M
Biodesix 49.09M
Zomedica 25.19M
ClearPoint Neuro 23.96M
DBV Technologies 15.73M
Revenue Rankings

AUGX News

More News